Bank Of Montreal Co Diagnostics, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$1.0 - $1.5 $74,910 - $112,365	74,910 New	74,910 $99,000
Q3 2022 Nov 10, 2022	SELL	$2.87 - $7.01 $94,710 - $231,330	-33,000 Reduced 52.88%	29,410 $96,000
Q2 2022 Aug 11, 2022	BUY	$3.76 - $6.29 $234,661 - $392,558	62,410 New	62,410 $349,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $28M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.